Supplier
RBFD Drug INC
RBFD Drug INC was paid $36.86M by Medicaid between Jan 2018 and Dec 2024, across 16 billing codes. Its largest line is A9276, Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply — 38% of everything it billed.
33Billing provider infoRBFD DRUG INC
BRONX, NY 10470
BRONX, NY 10470
33aNPI1174504765assigned 11/10/2005
33bProvider typeCommunity/Retail Pharmacy
28Total paid$36.86M
24GClaims81,706
24DCodes billed16
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community/Retail Pharmacy providers in New York
Rank by total paid#1 of 129
Median peer was paid$2K
This provider vs. median18,088×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,636 | $5.41M | |
| 2019 | 12,252 | $6.07M | |
| 2020 | 14,532 | $7.17M | |
| 2021 | 14,266 | $6.98M | |
| 2022 | 17,325 | $6.79M | |
| 2023 | 6,796 | $2.73M | |
| 2024incomplete | 4,899 | $1.72M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | 38% | 19,493 | 19,332 | $13.97M |
| A4230 | Infusion set for external insulin pump, non needle cannula type | 19% | 18,966 | 18,945 | $7.08M |
| E0784 | External ambulatory infusion pump, insulin | 18% | 1,625 | 1,617 | $6.80M |
| A9277 | Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | 12% | 9,461 | 9,439 | $4.39M |
| A4232 | Syringe with needle for external insulin pump, sterile, 3 cc | 5.6% | 18,532 | 18,510 | $2.05M |
| A4238 | Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 3.4% | 5,109 | 5,091 | $1.26M |
| K0553 | Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 1.7% | 2,921 | 2,873 | $628K |
| A9278 | Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system | <1% | 1,033 | 1,031 | $306K |
| A4239 | Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | <1% | 2,266 | 2,258 | $267K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | <1% | 905 | 890 | $82K |
| K0554 | Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system | <1% | 74 | 73 | $14K |
| A4259 | Lancets, per box of 100 | <1% | 521 | 514 | $5K |
4 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEISNER, DAVA (SP)
Parent organizationSTRIVE MEDICAL LLC